ask="7.20"
ask_size="700"
average_daily_volume="76302"
bid="5.68"
bid_size="1000"
book_value="5.08"
change="+0.00"
change_from_200_day_moving_average="0.42"
change_from_50_day_moving_average="1.23"
change_from_52_week_high="-6.62"
change_From_52_week_low="2.47"
change_in_percent="+0.00%"
close="6.13"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-3.75"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6295000"
high="6.27"
high_52_weeks="12.75"
last_trade_date="3/3/2017"
last_trade_price="6.13"
last_trade_size="107"
last_trade_time="4:00pm"
low="5.84"
low_52_weeks="3.66"
market_capitalization="82.33M"
moving_average_200_day="5.71"
moving_average_50_day="4.90"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="6.18"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+7.33%"
percent_change_from_50_day_moving_average="+25.07%"
percent_change_from_52_week_high="-51.92%"
percent_change_from_52_week_low="+67.49%"
previous_close="6.13"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.21"
price_per_sales="16.58"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="2.04"
stock_exchange="NGM"
symbol="AGLE"
volume="56581"
weeks_range_52="3.66 - 12.75"
